APA (7th ed.) Citation

RJ, M., B, E., S, O., TE, H., C, P., S, B., . . . Group, R. S. (2008). Efficacy of everolimus in advanced renal cell carcinoma: A double-blind, randomised, placebo-controlled phase III trial. Lancet, 372(9637), 449. https://doi.org/10.1016/s0140-6736(08)61039-9

Chicago Style (17th ed.) Citation

RJ, Motzer, et al. "Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-blind, Randomised, Placebo-controlled Phase III Trial." Lancet 372, no. 9637 (2008): 449. https://doi.org/10.1016/s0140-6736(08)61039-9.

MLA (9th ed.) Citation

RJ, Motzer, et al. "Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-blind, Randomised, Placebo-controlled Phase III Trial." Lancet, vol. 372, no. 9637, 2008, p. 449, https://doi.org/10.1016/s0140-6736(08)61039-9.